Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Takeda Selects leon-nanodrugs’s MicroJet Reactor for Feasibility | Contract Pharma

What are you searching for?

Sign in
Collaborations & Alliances

Takeda Selects leon-nanodrugs’s MicroJet Reactor for Feasibility

Assessment could potentially lead to the development of an innovative formulation of one of Takeda's pipeline products

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Takeda Pharmaceutical Co. Ltd. has selected leon-nanodrugs GmbH’s MicroJet Reactor for a feasibility assessment that could potentially lead to the development of an innovative formulation of one of their current pipeline products.
 
Under the companies’ collaboration, leon will support Takeda`s formulation efforts to optimize solubility, bioavailability and stability for one of Takeda’s current pipeline products for drug delivery using leon’s nanotechnology platform – MicroJet Reactor. The platform can be used from early compound screening to production of market batches. Results from this study could potentially result in a long-term collaboration and additional compounds may also be considered.
 
leon’s MJR technology offers reformulation options that address API’s that are poorly soluble in water, and can also lead to a superior profile for the API by increasing bioavailability, reducing inter patient variability, improving onset of action, etc.
 
Dr. Michael Mehler, chief executive officer of leon-nanodrugs GmbH said, “We are very pleased and proud that Takeda selected our MJR technology for a feasibility assessment with one of their compounds in development. It is a major milestone for our company to win Takeda, a globally leading pharmaceutical company, as a partner and we look forward to this collaboration with the goal to contributing to bring valuable new medicines to patients worldwide.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics